Using a set of 380 genes corresponding to 24 immune cell types, originally developed for application to colorectal cancer (Bindea et al., 2013) but later applied to melanoma (Nsengimana et al., 2018), we were also able to show that melanomas with low MITF expression were enriched in the melanoma “immunome,” while MITFHigh tumors exhibited reduced immune infiltration (Figure 1g). This evidence concerns the gene MITF and melanoma.